Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Revance Therapeutics, Inc.Listing unverified | Other | $41.2K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $28.7K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $38.7K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $37.5K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $83.5K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $57K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $185.6K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $21K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $84.2K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $101.7K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $47.5K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Exercise | $2.8K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $20.9K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $2.6K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $26.7K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $90.2K | SEC | ||
Revance Therapeutics, Inc.Listing unverified | Other | $84.8K | SEC |